Atlas Trials

Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.

Clinical trial NCT03361969 · COMPLETED

Trial details

NCT number
NCT03361969
Sponsor
Pantarhei Oncology B.V.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasm
Start date
2018-04-16
Primary completion
2020-05-15
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.